Print this page
Friday, 16 September 2011 16:08

InterVac opens at the University of Sask: will help ranchers

Written by 
Rate this item
(0 votes)

Premier Brad Wall and University of Saskatchewan (U of S) President Peter MacKinnon officially opened the International Vaccine Centre (InterVac) at the Saskatoon campus Sept. 16.



InterVac is part of the renowned U of S Vaccine and Infectious Disease Organization (VIDO) and will be a key player in Canada's vaccine preparedness strategy.

The Government of Saskatchewan has committed more than $57 million to InterVac. Total cost of the centre is $140 million.

"We are pleased to partner in this exciting new research development that will benefit all Canadians," Wall said. "This investment will further enhance Saskatchewan's growing reputation for innovative research and world-class life science facilities."

InterVac will develop vaccines to protect people and animals from the threat of emerging or persistent diseases such as avian influenza or tuberculosis. This new building will be one of the largest and most advanced Containment Level 3 facilities in the world for both human and large animal infectious diseases.

"We are grateful for the support and confidence of our partners in this outstanding vaccine research and development facility, which holds enormous potential to make significant headway against existing and emerging diseases," MacKinnon said.

The centre is expected to be operational in early 2012.

Since 2008, the Government of Saskatchewan has invested over $356 million in capital throughout the post-secondary system.

The Canadian Cattlemen’s Association (CCA) today welcomed the new International Vaccine Centre..

The CCA is a staunch proponent of government investment in scientific research. The work to be carried out at the $140-million facility will help to strengthen educational and training capacity, research collaboration and infrastructure, said Brad Wildeman, a CCA Past-President and Past Chair of the Vaccine and Infectious Disease Organization (VIDO) at the university.

“This new facility benefits everyone. Collaborations and partnerships with researchers throughout the world will enhance Canada’s research capacity, improve our ability to prepare for emerging diseases, train highly specialized workers and help ensure access to safe food and water,” he said.

 The CCA greatly values VIDO’s contributions to the beef industry, which include the development of effective vaccines to prevent economically important diseases affecting cow calf and feedlot sectors, said Wildeman. Industry also supports ongoing VIDO research pertaining to bovine respiratory disease, mycoplasma pneumonia and Johne’s disease with funding through the Beef Cattle Research Council.

“We are optimistic that the new InterVac facility will strengthen VIDO’s ability to help the Canadian beef industry continue to raise the world’s safest, healthiest and most nutritious beef,” Wildeman said.

Slated to be operational in 2012, the InterVac facility will be the largest of its kind in Canada and the only facility in Canada and the U.S. to house large animals. The facility received funding from a variety of sources, including a total of $49 million from the Government of Canada to build and equip the containment level 3 facility. InterVac will operate as part of VIDO.


 

The CCA greatly values VIDO’s contributions to the beef industry, which include the development of effective vaccines to prevent economically important diseases affecting cow calf and feedlot sectors, said Wildeman. Industry also supports ongoing VIDO research pertaining to bovine respiratory disease, mycoplasma pneumonia and Johne’s disease with funding through the Beef Cattle Research Council.

 

“We are optimistic that the new InterVac facility will strengthen VIDO’s ability to help the Canadian beef industry continue to raise the world’s safest, healthiest and most nutritious beef,” Wildeman said.

 

Read 849 times